Nephro-Urology Monthly

Published by: Kowsar

Mineral and Bone Disease in Black African Hemodialysis Patients: A Report From Senegal

Sidy Seck 1 , * , Mohamed Dahaba 2 , Elhadj Ka 3 , Mouhamadou Cisse 3 , Seigne Gueye 3 and Ahmet Lemrabott Tal 3
Authors Information
1 Internal Medicine and Nephrology Department, Faculty of Health Sciences, University Gaston Berger, Saint-Louis, Senegal
2 Hemodialysis Unit, Polyclinic ABC, Dakar, Senegal
3 Nephrology Department, University Hospital Aristide Le Dantec, Dakar, Senegal
Article information
  • Nephro-Urology Monthly: September 01, 2012, 4 (4); 613-616
  • Published Online: September 24, 2012
  • Article Type: Research Article
  • Received: February 9, 2012
  • Revised: April 14, 2012
  • Accepted: April 27, 2012
  • DOI: 10.5812/numonthly.4225

To Cite: Seck S, Dahaba M, Ka E, Cisse M, Gueye S, et al. Mineral and Bone Disease in Black African Hemodialysis Patients: A Report From Senegal, Nephro-Urol Mon. 2012 ; 4(4):613-616. doi: 10.5812/numonthly.4225.

Abstract
Copyright © 2012, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Martin KJ, Gonzalez EA. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol. 2007; 18(3): 875-85[DOI][PubMed]
  • 2. Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011; 26(6): 1368-76[DOI][PubMed]
  • 3. Moe S, Drüeke T, Block G, Cannata-Andia J, Elder G, Fukagawa M, et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009; 76[PubMed]
  • 4. Leye A, Diouf B, Ndongo S, Niang A, Ka EF, Pouye A, et al. [Secondary hyperparathyroidism of chronic hemodialysis]. Dakar Med. 2004; 49(1): 23-7[PubMed]
  • 5. Buargub MA, Nabulsi MF, Shafeh TA. Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients. Saudi J Kidney Dis Transpl. 2006; 17(3): 401-7[PubMed]
  • 6. Sanusi AA, Arogundade FA, Oladigbo M, Ogini LM, Akinsola A. Prevalence and pattern of renal bone disease in end stage renal disease patients in Ile-Ife, Nigeria. West Afr J Med. 2010; 29(2): 75-80[PubMed]
  • 7. Moore C, Yee J, Malluche H, Rao DS, Monier-Faugere MC, Adams E, et al. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol. 2009; 4(9): 1484-93[DOI][PubMed]
  • 8. Araujo SM, Ambrosoni P, Lobao RR, Caorsi H, Moyses RM, Barreto FC, et al. The renal osteodystrophy pattern in Brazil and Uruguay: an overview. Kidney Int Suppl. 2003; (85)-6[DOI][PubMed]
  • 9. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, et al. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int. 1993; 44(4): 860-6[DOI][PubMed]
  • 10. Santoso D, Yogiantoro M, Tomino Y. Osteodystrophy in Indonesian haemodialysis patients. Nephrology (Carlton). 2003; 8(5): 261-5[DOI][PubMed]
  • 11. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42: 1-201[DOI]
  • 12. Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon. Kidney Int Suppl. 2002; (82)-80[DOI][PubMed]
  • 13. Odenigbo UC, Ijoma CK, Ulasi I, Udeh AC, Ibeh CC. The prevalence of radiological markers of renal osteodystrophy in patients with chronic renal failure in Enugu. Niger J Clin Pract. 2006; 9(2): 147-52[PubMed]
  • 14. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15(7): 1014-21[DOI][PubMed]
  • 15. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2009; 24(3): 948-55[DOI][PubMed]
  • 16. Gallieni M, Cucciniello E, D'Amaro E, Fatuzzo P, Gaggiotti A, Maringhini S, et al. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study. J Nephrol. 2002; 15(2): 165-70[PubMed]
  • 17. Gupta A. Renal bone disease in black dialysis patients: are algorithms developed for white dialysis patients valid? Nephrol Dial Transplant. 2001; 16(7): 1518-9[DOI][PubMed]
  • 18. Fan SL, Chan A, Raftery MJ, Yaqoob MM. Race and sex: predictors of the severity of hyperparathyroidism in peritoneal dialysis patients. Nephrology (Carlton). 2006; 11(1): 15-20[DOI][PubMed]
  • 19. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol. 2000; 11(2): 330-4[PubMed]
  • 20. Omije D, Norris K, Wang J, Pan D, Kermah D, Gupta A. Race is a major determinant of secondary hyperparathyroidism in uremic patients: comparative study of Blacks and Hispanics. Clin Nephrol. 2008; 70(4): 312-8[PubMed]
  • 21. Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, et al. Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int. 2004; 65(5): 1914-26[DOI][PubMed]
  • 22. Goodman WG. Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention. Nephrol Dial Transplant. 2002; 17(2): 204-7[DOI][PubMed]
  • 23. Carter JL, O'Riordan SE, Eaglestone GL, Delaney MP, Lamb EJ. Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study. Nephrol Dial Transplant. 2008; 23(11): 3554-65[DOI][PubMed]
  • 24. Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010; (117)-21[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments